Enveric Biosciences, Inc. (ENVB)
1.36
-0.01
(-0.73%)
USD |
NASDAQ |
Sep 01, 15:48
Enveric Biosciences Total Long Term Debt (Quarterly) : 0.00 for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.0099M |
| March 31, 2022 | 0.0401M |
| December 31, 2021 | 0.0689M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.1486M |
| March 31, 2021 | 0.00 |
| September 30, 2020 | 2.558M |
| June 30, 2020 | 3.588M |
| March 31, 2020 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.0064M |
| September 30, 2018 | 1.258M |
| June 30, 2018 | 2.583M |
| March 31, 2018 | 2.685M |
| December 31, 2017 | 3.130M |
| September 30, 2017 | 3.231M |
| June 30, 2017 | 2.990M |
| March 31, 2017 | 2.674M |
| December 31, 2016 | 1.942M |
| September 30, 2016 | 6.567M |
| June 30, 2016 | 5.00M |
| March 31, 2016 | 6.477M |
| December 31, 2015 | 5.00M |
| September 30, 2015 | 5.00M |
| June 30, 2015 | 5.00M |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| LENZ Therapeutics, Inc. | 0.122M |
| Impact BioMedical, Inc. | 0.00 |
| ANI Pharmaceuticals, Inc. | 610.49M |
| Corcept Therapeutics, Inc. | 7.504M |
| Veru, Inc. | 1.908M |